Association of HLA-DR2-Related Haplotype (HLA-DRB5*01-DRB1*1501-DQB1*0602) in Patients with Multiple Sclerosis in Khuzestan Province
Iranian Journal of Child Neurology,
Vol. 15 No. 3 (2021),
1 July 2021
Multiple sclerosis is a partially heritable autoimmune disease. HLA-DR2 is the largest identified genetic risk factor for MS. The largest identified genetic risk factor is haplotype from the MHC class II HLA-DR2 which increases risk of disease. The HLA-DR2 distribution in MS patients has been confirmed but contradictory outcomes have been found although its effect on ethnicity and gender is unclear. Since, there are no data regard to the association of HLA-DR2 (HLA-DRB1*1501-DRB5*01-DQB1*0602) with MS in Khuzestan, and because of ethnic diversity, investigating the association of HLA-DR2 with MS disability in both sex and ethnicity, was the aim of this study.
Materials & Methods
A total of 399 individuals were recruited in the study. HLA typing was conducted using the polymerase chain reaction amplification with sequence-specific primers (PCR-SSP) technology. Moreover, HLA-DR2 association with MS was analyzed. Also, probable association with gender, ethnicity, EDSS, MS clinical course was examined by chi square test.
HLA-DRB5*01--DQB1*0602- as the most common HLA haplotype was found in both patient and control groups. In contrast, DRB5*01+-DRB1*1501+-DQB1*0602- frequency was very low. It was observed that no haplotype has association with MS susceptibility. Interestingly, none of the haplotypes showed association with ethnicity, sex, EDSS and MS course except for HLA-DRB5*01+-DRB1*1501+-DQB1*0602- haplotype that was positively associated with EDSS steps 5 to 10 (p=0.014) and non-RRMS (p = 0.023).
There was no association between HLA-DR2 and MS susceptibility. However, the higher HLA-DRB5*01+-DRB1*1501+-DQB1*0602- frequency may play a role in MS development. Also, HLA-DR2 did not increase significantly concerning clinical course, ethnicity, sex, and EDSS. This study further supports the importance of replication studies as susceptible loci that might differ in various ethnicities. Therefore, it is concluded that the association between HLA-DR2 and MS is more allelic than haplotypic in Khuzestan
- Multiple sclerosis
How to Cite
Marrack P, Kappler J, Kotzin BL. Autoimmunedisease: why and where it occurs. Nat Med. 2001;7(8):899-905.
Sawcer S, Franklin RJ, Ban M. Multiple sclerosis genetics. Lancet Neurol. 2014;13(7):700-709
Kouri I, Papakonstantinou S, Bempes V, et al. HLA associations with multiple sclerosis in Greece. J Neurol Sci. 2011;308(1-2):28-31.45
Weissert R. The immune pathogenesis of multiple sclerosis. JNIP. 2013;8(4):857-66.
Grant P. Parnell, David R. The Multiple Sclerosis (MS) Genetic Risk Factors indicate both Acquired and innate immune Cell Subsets Contribute to MS Pathogenesis and identify novel Therapeutic Opportunities. Front Immunol. 2017;8:425.
Lincoln MR, Montpetit A, Cader MZ, et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet. 2005;37(10):1108-12.
Naito S, Namerow N, Mickey MR, Terasaki PI. Multiple sclerosis: association with HL-A3. Tissue Antigens. 1972;2(1):1–4.
Alcina A, Abad-Grau Mdel M, Fedetz M, et al. Multiple Sclerosis Risk Variant HLADRB1* 1501 Associates with High Expression of DRB1 Gene in Different Human Populations. PLoS One. 2012;7(1):e29819.
Gregersen JW, Kranc KR, Ke X, et al. Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature. 2006;443(7111):574-7.
Amirzargar A, Mytilineos J, Yousefipour A, et al. HLA class II (DRB1, DQA1, and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients. Eur J Immunogenet. 1998;25(4):297-301.
Smith KJ, Pyrdol J, Gauthier L, et al. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. J Exp Med. 1998;188(8):1511-20.
Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurol. 1983;33:1444-52.
McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiplesclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121-7.
Masterman T, Ligers A, Olsson T, et al. HLADR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol. 2000;48(2):211–9.
McElroy JP, Cree BA, Caillier SJ, et al. Refining the association of MHC with multiple sclerosis in African Americans. Ann Neurol. 2010;48(2):211- 9.
Marrosu MG, Murru MR, Costa G, et al. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet. 1998;7(8):1235-7.
Lincoln MR, Ramagopalan SV, Chao MJ, et al. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci USA. 2009;106(18):7542-7.
Oksenberg JR, Barcellos LF, Cree BA, et al. Mapping Multiple Sclerosis Susceptibility to the HLA-DR Locus in African Americans. Am J Hum Genet. 2004;74(1):160–7.
Kaushansky N, Altmann DM, Ascough S, et al. HLA-DQB1*0602 Determines Disease Susceptibility in a New “Humanized” Multiple Sclerosis Model in HLA-DR15 (DRB1*1501;DQB1*0602) Transgenic Mice. J Immunol. 2009;183(5):3531-41.
Etzensperger R, McMahon RM, Jones EY, et al.Dissection of the multiple sclerosis-associated DR2 haplotype. J Autoimmun. 2008;31(3):201–7.
Caballero A, Alvés-León S, Papais-Alvarenga R, et al. DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians. Tissue Antigens. 1999;54(5):524–6.
Serjeantson SW, Gao X, Hawkins BR, et al. Novel HLA-DR2-Related Haplotypes in Hong 46 Association of HLA-DR2-Related Haplotype (HLA-DRB5*01-DRB1*1501-DQB1*0602) Kong Chinese implicate the DQB1*0602 allele in susceptibility to Multiple Sclerosis. Eur J Immunogenet.1992;19(1-2):11-19.
- Abstract Viewed: 609 times